Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

ESC 2024 Insights: Comparison of Different Calcium Modification Stra…

ESC 2024 Insights

K. Yasumura

Therapeutic Hypothermia After Cardiac Arrest

John McPherson

DAPT Following ACS: Does One Size Fit All?

Canadian Collaborative Research Network

M. Bonaca

TCT 2024 Insights: A Contemporary Analysis and Outcomes of Orbital A…

TCT 2024 Insights

H. Amin

Basics of OCT Imaging

FACET

N. Pinilla-Echeverri

TCT 2024 Insights: Insights from the DanGer Shock and ECLS-Shock Tri…

TCT 2024 Insights

G. Tarantini

Q&A: Are We Underusing CABG?

Cedars Sinai

J. Chikwe

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari